HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$79.57
Day range
$74.80 - $81.52
Year range
$10.81 - $94.47
Market cap
1.09B USD
Avg Volume
270.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.28M | -33.24% |
Net income | -35.26M | 19.62% |
Net profit margin | — | — |
Earnings per share | -2.28 | 19.72% |
EBITDA | -33.23M | 27.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 153.09M | -22.03% |
Total assets | 177.47M | -20.26% |
Total liabilities | 140.64M | 218.95% |
Total equity | 36.83M | — |
Shares outstanding | 14.54M | — |
Price to book | 31.33 | — |
Return on assets | -43.39% | — |
Return on capital | -52.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -35.26M | 19.62% |
Cash from operations | -33.82M | -11.70% |
Cash from investing | -7.00K | 97.17% |
Cash from financing | 352.00K | — |
Net change in cash | -33.48M | -9.67% |
Free cash flow | -22.71M | -39.24% |
About
Founded
2024
Headquarters
Website
Employees
159
